Your browser doesn't support javascript.
loading
Quality of life predicts overall survival in women with platinum-resistant ovarian cancer: an AURELIA substudy.
Roncolato, F T; Gibbs, E; Lee, C K; Asher, R; Davies, L C; Gebski, V J; Friedlander, M; Hilpert, F; Wenzel, L; Stockler, M R; King, M; Pujade-Lauraine, E.
Afiliação
  • Roncolato FT; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney.
  • Gibbs E; Macarthur Cancer Therapy Centre, Campbelltown.
  • Lee CK; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney.
  • Asher R; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney.
  • Davies LC; Medical Oncology, St George Hospital, Sydney.
  • Gebski VJ; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney.
  • Friedlander M; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney.
  • Hilpert F; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney.
  • Wenzel L; Medical Oncology, Prince of Wales Hospital, Sydney, Australia.
  • Stockler MR; Gynecology & Obstetrics, University of Schleswig-Holstein, Kiel, Germany.
  • King M; Public Health, University of California, Irvine, USA.
  • Pujade-Lauraine E; National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney.
Ann Oncol ; 28(8): 1849-1855, 2017 Aug 01.
Article em En | MEDLINE | ID: mdl-28595285

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Neoplasias Ovarianas / Qualidade de Vida Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organoplatínicos / Neoplasias Ovarianas / Qualidade de Vida Idioma: En Ano de publicação: 2017 Tipo de documento: Article